Nitroxyl donors retain their depressor effects in hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 6, 2013, Pages

  Irvine, Jennifer C ^a   Ravi, Ravina M ^a   Kemp Harper, Barbara K ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angeli's salt; Blood pressure; Isopropylamine; Nitric oxide; NONOate; Vasorelaxation

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ANTIHYPERTENSIVE AGENT; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG EFFECT; DRUG INFUSION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; ISOLATED ORGAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ANGELI'S SALT; BLOOD PRESSURE; ISOPROPYLAMINE/NONOATE; NITRIC OXIDE; VASORELAXATION;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; NITRIC OXIDE DONORS; NITROGEN OXIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; TREATMENT OUTCOME; VASODILATION; VASODILATOR AGENTS;

EID: 84884376753     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00630.2012     Document Type: Article

References (36)

1. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, Kemp-Harper BK. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol 157: 540-550, 2009.
2. Boesgaard S, Petersen JS, Aldershvile J, Poulsen HE, Flachs H. Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model. J Pharmacol Exp Ther 258: 851-856, 1991.
3. Brandes R, Kim D, Schmitz-Winnethal F, Amidi M, Godecke A, Mulsch A, Busse R. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension 35: 231-236, 2000.
4. Bullen ML, Miller AA, Andrews KL, Irvine JC, Ritchie RH, Sobey CG, Kemp-Harper BK. Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxid Redox Signal 14: 1675-1686, 2011.
5. Bullen ML, Miller AA, Dharmarajah J, Drummond GR, Sobey CG, Kemp-Harper BK. Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia. Am J Physiol Heart Circ Physiol 301: H1405-H1414, 2011.
6. De Witt BJ, Marrone JR, Kaye AD, Keefer LK, Kadowitz PJ. Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. Eur J Pharmacol 430: 311-315, 2001.
7. Favaloro JL, Kemp-Harper BK. Redox variants of NO (NO·and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Am J Physiol Heart Circ Physiol 296: H1274-H1280, 2009.
8. Fukuto JM, Chiang K, Hszieh R, Wong PSY, Chaudhurri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther 263: 546-551, 1992.
9. Fukuto JM, Carrington SJ. HNO signaling mechanisms. Antioxid Redox Signal 14: 1649-1657, 2011.
10. v channels to vasodilate resistance arteries. Hypertension 41: 1301-1307, 2003.
11. Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK. Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension 49: 885-892, 2007.
12. Irvine JC, Kemp-Harper BK, Widdop RE. Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO. Antioxid Redox Signal 14: 1615-1624, 2011.
13. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK. Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 29: 601-608, 2008.
14. Kloss S, Bouloumie A, Mulsch A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35: 43-47, 2000.
15. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999.
16. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10: 1045-1059, 2008.
17. Lewis SJ, Hashmi-Hill MP, Owen JR, Sandock K, Robertson TP, Bates JN. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats. Vascul Pharmacol 44: 476-490, 2006.
18. Ma XL, Gao F, Liu GL, Lopez BL, Christopher TA, Fukuto JM, Wink DA, Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci USA 96: 14617-14622, 1999.
19. Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ, Cologna SM, Dutton AS, Champion HC, Mancardi D, Tocchetti CG, Saavedra JE, Keefer LK, Houk KN, Fukuto JM, Kass DA, Paolocci N, Wink DA. Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo. J Med Chem 48: 8220-8228, 2005.
20. Miranda KM, Yamada K, Espey MG, Thomas DD, DeGraff WG, Mitchell JB, Krishna MC, Colton CA, Wink DA. Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite. Arch Biochem Biophys 401: 134-144, 2002.
21. Mondoro TH, Ryan BB, Hrinczenko BW, Schechter AN, Vostal JG, Alayash AI. Biological action of nitric oxide donor compounds on platelets from patients with sickle cell disease. Br J Haematol 112: 1048-1054, 2001.
22. Nishikawa Y, Kanki H, Ogawa S. Differential effects of N-acetylcysteine on nitroglycerin-and nicorandil-induced vasodilation in human coronary circulation. J Cardiovasc Pharmacol 32: 21-28, 1998.
23. - in failing hearts: independence from β-adrenergic signaling. Proc Natl Acad Sci USA 100: 5537-5542, 2003.
24. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA 98: 10463-10468, 2001.
25. Papapetropoulos A, Marczin N, Snead MD, Cheng C, Milici A, Catravas JD. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 23: 476-484, 1994.
26. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 338: 520-531, 1998.
27. Ruetten H, Zabel U, Linz W, Schmidt HH. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85: 534-541, 1999.
28. Tocchetti CG, Stanley BA, Murray CI, Sivakumaran V, Donzelli S, Mancardi D, Pagliaro P, Gao WD, van Eyk J, Kass DA, Wink DA, Paolocci N. Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function. Antioxid Redox Signal 14: 1687-1698, 2011.
29. 2+ cycling. Circ Res 100: 96-104, 2007.
30. Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, Kibbe MR. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury. J Vasc Surg 51: 1248-1259, 2010.
31. Widdop RE, Verberne AJ, Jarrott B, Louis WJ. Impaired arterial baroreceptor reflex and cardiopulmonary vagal reflext in conscious spontaneously hypertensive rats. J Hypertens 8: 269-275, 1990.
32. Wink DA, Feelisch M, Fukuto JM, Christodoulou D, Jourd'heuil D, Grisham MB, Vodovotz Y, Cook JA, Krishna M, DeGraff WG, Kim S, Gamson J, Mitchell JB. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys 351: 66-74, 1998.
33. Wynne BM, Labazi H, Tostes RC, Webb RC. Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacol Res 65: 41-47, 2012.
34. Yuill KH, Yarova P, Kemp-Harper BK, Garland CJ, Dora KA. A novel role for HNO in local and spreading vasodilatation in rat mesenteric resistance arteries. Antioxid Redox Signal 14: 1625-1635, 2011.
35. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35: 1055-1061, 2000.
36. Zhou ZH, Jiang JL, Peng J, Deng HW, Li YJ. Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide. Eur J Pharmacol 439: 129-134, 2002.